About Vijaysar / Indian Kino Tree
Heartwood extract (vijaysar) with a multicenter double-blind RCT (n=349) comparing it to tolbutamide in newly diagnosed type 2 diabetics, showing comparable glucose-lowering efficacy. Evidence is largely limited to this one (older, India-based) trial plus supporting animal data — no independent replication or meta-analysis exists. Not a substitute for prescribed diabetes medication.
What Vijaysar / Indian Kino Tree supports
- One large clinical trial showed blood-glucose-lowering comparable to a standard diabetes drug in newly diagnosed type 2 diabetes — not yet independently replicated
How much Vijaysar / Indian Kino Tree to take
The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.
Effective
2000–4000
mg
Dose range used in the largest published RCT (heartwood aqueous extract) for blood glucose in newly diagnosed type 2 diabetes.
Clinical evidence
Moderate clinical evidence. One sizeable RCT vs. an active drug comparator; promising but not replicated or meta-analyzed.
NIH Fact Sheet